Fatal infection in children with lupus nephritis treated with intravenous cyclophosphamide

Pediatric Nephrology

Volumn 24, Issue 7, 2009, Pages 1337-1343

  Laoprasopwattana, Kamolwish ^a,b   Dissaneewate, Pornsak ^a   Vachvanichsanong, Prayong ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Infection; Intravenous cyclophosphamide; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C3; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; METHYLPREDNISOLONE;

ACINETOBACTER INFECTION; ADOLESCENT; ARTICLE; ASPERGILLOSIS; BACTERIAL PNEUMONIA; BRAIN ABSCESS; CANDIDIASIS; CENTRAL NERVOUS SYSTEM INFECTION; CHILD; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG FATALITY; DRUG PULSE THERAPY; DRUG RESPONSE; FEMALE; GRAM NEGATIVE INFECTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; KLEBSIELLA INFECTION; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOSIS; NOCARDIOSIS; PERITONITIS; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; PROTEINURIA; SALMONELLOSIS; SEPTICEMIA; SIDE EFFECT; STAPHYLOCOCCUS INFECTION; STRONGYLOIDIASIS; THAILAND; TUBERCULOSIS;

CHILD; CYCLOPHOSPHAMIDE; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, INTRAVENOUS; LUPUS NEPHRITIS; MALE; MYCOSES; RISK FACTORS;

EID: 67349268927     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-009-1152-7     Document Type: Article

References (41)

1. Austin HA 3rd, Klippel JH, Balow JE, le Riche NG, Steinberg AD, Plotz PH, Decker JL (1986) Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314:614-619
2. Lehman TJ, Onel K (2000) Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus. J Pediatr 136:243-247
3. Gonzalez B, Hernandez P, Olguin H, Miranda M, Lira L, Toso M, Quezada A, Norambuena X, Talesnik E, Mendez C, Navarrete C (2005) Changes in the survival of patients with systemic lupus erythematosus in childhood: 30 years experience in Chile. Lupus 14:918-923
4. Kang I, Park SH (2003) Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol 15:528-534
5. Duffy KN, Duffy CM, Gladman DD (1991) Infection and disease activity in systemic lupus erythematosus: A review of hospitalized patients. J Rheumatol 18:1180-1184
6. Hellmann DB, Petri M, Whiting-O'Keefe Q (1987) Fatal infections in systemic lupus erythematosus: The role of opportunistic organisms. Medicine (Baltimore) 66:341-348
7. Bosch X, Guilabert A, Pallares L, Cerveral R, Ramos-Casals M, Bove A, Ingelmo M, Font J (2006) Infections in systemic lupus erythematosus: A prospective and controlled study of 110 patients. Lupus 15:584-589
8. Pryor BD, Bologna SG, Kahl LE (1996) Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 39:1475-1482
9. Chen YS, Yang YH, Lin YT, Chiang BL (2004) Risk of infection in hospitalized children with systemic lupus erythematosus: A 10-year follow-up. Clin Rheumatol 23:235-238
10. Ng WL, Chu CM, Wu AK, Cheng VC, Yuen KY (2006) Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus. QJM 99:37-47
11. Pattaragarn A, Sumboonnanonda A, Parichatikanond P, Supavekin S, Suntornpoch V, Vongjirad A (2005) Systemic lupus erythematosus in Thai children: Clinicopathologic findings and outcome in 82 patients. J Med Assoc Thai 88(Suppl 8):S232-S241
12. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Aydintug AO, Jedryka-Goral A, de Ramon E, Fernandez-Nebro A, Galeazzi M, Haga HJ, Mathieu A, Houssiau F, Ruiz-Irastorza G, Ingelmo M, Hughes GR (1999) Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 78:167-175
13. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J (1995) Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol 22:1259-1264
14. Kim WU, Min JK, Lee SH, Park SH, Cho CS, Kim HY (1999) Causes of death in Korean patients with systemic lupus erythematosus: A single center retrospective study. Clin Exp Rheumatol 17:539-545
15. Ward MM, Pyun E, Studenski S (1995) Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort. Arthritis Rheum 38:1492-1499
16. Janwityanuchit S, Totemchokchyakarn K, Krachangwongchai K, Vatanasuk M (1993) Infection in systemic lupus erythematosus. J Med Assoc Thai 7:542-548
17. Opastirakul S, Chartapisak W (2005) Infection in children with lupus nephritis receiving pulse and oral cyclophosphamide therapy. Pediatr Nephrol 20:1750-1755
18. Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gul A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R (2002) Immunosuppressive therapy in lupus nephritis: The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum 46:2121-2131
19. Noel V, Lortholary O, Casassus P, Cohen P, Genereau T, Andre MH, Mouthon L, Guillevin L (2001) Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis 60:1141-1144
20. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
21. Vachvanichsanong P, Dissaneewate P, Winn T (2004) Intravenous cyclophosphamide for lupus nephritis in Thai children. Scand J Rheumatol 33:339-342
22. King CK, Glass R, Bresee JS, Duggan C (2003) Managing acute Gastroenteritis among children: Oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep 52(RR-16):1-16
23. Tranaeus A, Heimburger O, Lindholm B (1989) Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): Diagnostic findings, therapeutic outcome and complications. Perit Dial Int 9:179-190
24. Gladman DD, Hussain F, Ibanez D, Urowitz MB (2002) The nature and outcome of infection in systemic lupus erythematosus. Lupus 11:234-239
25. Tsao CH, Chen CY, Ou LS, Huang JL (2002) Risk factors of mortality for Salmonella infection in systemic lupus erythematosus. J Rheumatol 29:1214-1218
26. Shahram F, Akbarian M, Davatchi F (1993) Salmonella infection in systemic lupus erythematosus. Lupus 2:55-59
27. Berenguer J, Buck M, Witebsky F, Stock F, Pizzo PA, Walsh TJ (1993) Lysis centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. Disseminated versus single-organ infection. Diagn Microbiol Infect Dis 17:103-109
28. Ward MM, Donald F (1999) Pneumocystis carinii pneumonia in patients with connective tissue diseases: The role of hospital experience in diagnosis and mortality. Arthritis Rheum 42:780-789
29. Mok CC, Yuen KY, Lau CS (1997) Nocardiosis in systemic lupus erythematosus. Semin Arthritis Rheum 26:675-683
30. Leong KP, Tee NW, Yap WM, Chee TS, Koh ET (2000) Nocardiosis in patients with systemic lupus erythematosus. The Singapore Lupus Study Group. J Rheumatol 27:1306-1312
31. Mora CS, Segami MI, Hidalgo JA (2006) Strongyloides stercoralis hyperinfection in systemic lupus erythematosus and the antiphospholipid syndrome. Semin Arthritis Rheum 36:135-143
32. Livneh A, Coman EA, Cho SH, Lipstein-Kresch E (1988) Strongyloides stercoralis hyperinfection mimicking systemic lupus erythematosus flare. Arthritis Rheum 31:930-931
33. Scowden EB, Schaffner W, Stone WJ (1978) Overwhelming strongyloidiasis: an unappreciated opportunistic infection. Medicine (Baltimore) 57:527-544
34. Laoprasopwattana K, Pruekprasert P, Laosombat V, Wongchanchailert M (2007) Clinical outcome of febrile neutropenia in children with cancer using ceftazidime and aminoglycosides. Pediatr Hematol Oncol 24:595-606
35. Hsu CL, Chen KY, Yeh PS, Hsu YL, Chang HT, Shau WY, Yu CL, Yang PC (2005) Outcome and prognostic factors in critically ill patients with systemic lupus erythematosus: A retrospective study. Crit Care 9:R177-R183
36. Williams FM, Chinn S, Hughes GR, Leach RM (2002) Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome. Ann Rheum Dis 61:414-421
37. Levy M, Montes de Oca M, Claude-Babron M (1994) Unfavorable outcomes (end-stage renal failure/death) in childhood onset systemic lupus erythematosus. A multicenter study in Paris and its environs. Clin Exp Rheumatol 12(Suppl 10):S63-S68
38. Whitelaw DA, Gopal R, Freeman V (2005) Survival of patients with SLE admitted to an intensive care unit-a retrospective study. Clin Rheumatol 24:223-227
39. Wallace DJ, Podell T, Weiner J, Klinenberg JR, Forouzesh S, Dubois EL (1981) Systemic lupus erythematosus-survival patterns. Experience with 609 patients. JAMA 245:934-938
40. Manger K, Manger B, Repp R, Geisselbrecht M, Geiger A, Pfahlberg A, Harrer T, Kalden JR (2002) Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis 61:1065-1070
41. Mok CC, Lee KW, Ho CT, Lau CS, Wong RW (2000) A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology (Oxford) 39:399-406